{"id":"fumaric-acids","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Gastrointestinal disturbances"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL1201498","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Fumaric acid has been shown to have immunomodulatory effects, reducing the production of pro-inflammatory cytokines such as TNF-alpha and IL-1beta, which are involved in the pathogenesis of psoriasis.","oneSentence":"Fumaric acid is thought to modulate the immune system by inhibiting the production of pro-inflammatory cytokines.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:33:16.900Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Psoriasis"}]},"trialDetails":[{"nctId":"NCT03331835","phase":"PHASE4","title":"A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2017-11-03","conditions":"Psoriasis Vulgaris","enrollment":210},{"nctId":"NCT06161688","phase":"PHASE2","title":"Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID","status":"ACTIVE_NOT_RECRUITING","sponsor":"Timothy Henrich","startDate":"2024-04-09","conditions":"Long COVID, Post Acute Sequelae of COVID-19, Post-Acute COVID-19","enrollment":40},{"nctId":"NCT01848028","phase":"","title":"PsoBest - The German Psoriasis Registry","status":"RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2008-01","conditions":"Psoriasis, Psoriatic-arthritis","enrollment":3500},{"nctId":"NCT01706692","phase":"","title":"Swiss Dermatology Network of Targeted Therapies (SDNTT)","status":"RECRUITING","sponsor":"Swiss Dermatology Network for Targeted Therapies","startDate":"2011-02","conditions":"Psoriasis","enrollment":1121},{"nctId":"NCT05008549","phase":"NA","title":"A Study to Assess the Synergistic Effects of a Cranberry Beverage on Cognitive Function","status":"COMPLETED","sponsor":"Ocean Spray Cranberries, Inc.","startDate":"2021-07-26","conditions":"Attention, Mood","enrollment":25},{"nctId":"NCT02954081","phase":"","title":"APremilast After FumaRic Acid Ester Treatment","status":"COMPLETED","sponsor":"Amgen","startDate":"2017-01-26","conditions":"Psoriasis","enrollment":687},{"nctId":"NCT05260346","phase":"NA","title":"Modulation of the Gut-brain Axis by Cranberries: Impact on University Students' Mental Wellbeing","status":"COMPLETED","sponsor":"King's College London","startDate":"2022-01-10","conditions":"Healthy","enrollment":64},{"nctId":"NCT03107871","phase":"PHASE2","title":"Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Albert Park","startDate":"2018-08-31","conditions":"Cmv Congenital, CMV, Congenital Cmv","enrollment":52},{"nctId":"NCT02951533","phase":"PHASE3","title":"A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Janssen-Cilag G.m.b.H","startDate":"2016-12-12","conditions":"Psoriasis","enrollment":119},{"nctId":"NCT02984397","phase":"PHASE3","title":"Chronic Widespread Pain and White Blood Cell Activation","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2016-12","conditions":"Widespread Chronic Pain","enrollment":44},{"nctId":"NCT02634801","phase":"PHASE3","title":"A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2016-01-20","conditions":"Plaque Psoriasis","enrollment":162},{"nctId":"NCT02337426","phase":"PHASE1","title":"Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2015-02-13","conditions":"Adult Brain Glioblastoma, Adult Giant Cell Glioblastoma, Adult Gliosarcoma","enrollment":12},{"nctId":"NCT02474082","phase":"PHASE3","title":"Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis.","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2015-04","conditions":"Psoriasis","enrollment":202},{"nctId":"NCT01812954","phase":"","title":"Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis","status":"COMPLETED","sponsor":"Jochen Schmitt.","startDate":"2013-03","conditions":"Psoriasis","enrollment":1},{"nctId":"NCT00254982","phase":"PHASE3","title":"Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-08","conditions":"Psoriasis","enrollment":593},{"nctId":"NCT00466817","phase":"PHASE3","title":"Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-06","conditions":"Cytomegalovirus Infection","enrollment":109},{"nctId":"NCT02376478","phase":"","title":"On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2009-12","conditions":"Psoriasis, Inflammatory Bowel Diseases","enrollment":222},{"nctId":"NCT01321164","phase":"PHASE3","title":"Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2011-04","conditions":"Plaque Psoriasis","enrollment":30},{"nctId":"NCT01352988","phase":"PHASE2","title":"Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2011-07","conditions":"Lupus Erythematosus, Cutaneous","enrollment":11},{"nctId":"NCT01088165","phase":"PHASE4","title":"The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2010-05","conditions":"Psoriasis, Cardiovascular Diseases, Diabetes Mellitus, Type 2","enrollment":66},{"nctId":"NCT00811005","phase":"PHASE3","title":"Fumaric Acid Ester-PUVA Therapy Versus Acitretin -PUVA Therapy in Pustular Palmoplantar Psoriasis","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2008-10","conditions":"Pustular Palmoplantar Psoriasis","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":166,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Fumaric acids","genericName":"Fumaric acids","companyName":"Swiss Dermatology Network for Targeted Therapies","companyId":"swiss-dermatology-network-for-targeted-therapies","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fumaric acid is thought to modulate the immune system by inhibiting the production of pro-inflammatory cytokines. Used for Psoriasis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}